Immunity and tolerance induced by intestinal mucosal dendritic cells

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Aliberti, Julio ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; INFLAMMASOME; INTERLEUKIN 1BETA;

CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL POPULATION; DENDRITIC CELL; ENTERITIS; HUMAN; IMMUNOLOGICAL TOLERANCE; INFECTION; INTESTINE CELL; INTESTINE MUCOSA; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; ANIMAL; CYTOLOGY; IMMUNITY; IMMUNOLOGY; METABOLISM;

ANIMALS; DENDRITIC CELLS; HUMANS; IMMUNITY; INTESTINAL MUCOSA; T-LYMPHOCYTES, REGULATORY;

EID: 84962233383     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/3104727     Document Type: Review

References (105)

1. A. L. Hart, H. O. Al-Hassi, R. J. Rigby et al. , "Characteristics of intestinal dendritic cells in inflammatory bowel diseases, " Gastroenterology, vol. 129, no. 1, pp. 50-65, 2005.
2. B. Kelsall, "Recent progress in understanding the phenotype and function of intestinal dendritic cells and macrophages, " Mucosal Immunology, vol. 1, no. 6, pp. 460-469, 2008.
3. J. L. Coombes and F. Powrie, "Dendritic cells in intestinal immune regulation, " Nature Reviews Immunology, vol. 8, no. 6, pp. 435-446, 2008.
4. B. Johansson-Lindbom, M. Svensson, O. Pabst et al. , "Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing, " Journal of Experimental Medicine, vol. 202, no. 8, pp. 1063-1073, 2005.
5. J. L. Coombes, K. R. R. Siddiqui, C. V. Arancibia-Carcamo et al. , "A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β-and retinoic acid-dependent mechanism, " The Journal of Experimental Medicine, vol. 204, no. 8, pp. 1757-1764, 2007.
6. E. Jaensson, H. Uronen-Hansson, O. Pabst et al. , "Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans, " Journal of Experimental Medicine, vol. 205, no. 9, pp. 2139-2149, 2008.
7. C.-M. Sun, J. A. Hall, R. B. Blank et al. , "Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid, " Journal of ExperimentalMedicine, vol. 204, no. 8, pp. 1775-1785, 2007.
8. M. Bersudsky, L. Luski, D. Fishman et al. , "Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice, " Gut, vol. 63, no. 4, pp. 598-609, 2014.
9. M. Bogunovic, F. Ginhoux, J. Helft et al. , "Origin of the lamina propria dendritic cell network, " Immunity, vol. 31, no. 3, pp. 513-525, 2009.
10. D. V. Ostanin, K. P. Pavlick, S. Bharwani et al. , "T cell-induced inflammation of the small and large intestine in immunodeficient mice, " American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 290, no. 1, pp. G109-G119, 2006.
11. M. Rescigno, M. Urbano, B. Valzasina et al. , "Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria, " Nature Immunology, vol. 2, no. 4, pp. 361-367, 2001.
12. O. Schulz, E. Jaensson, E. K. Persson et al. , "Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions, " Journal of Experimental Medicine, vol. 206, no. 13, pp. 3101-3114, 2009.
13. C. Varol, A. Vallon-Eberhard, E. Elinav et al. , "Intestinal lamina propria dendritic cell subsets have different origin and functions, " Immunity, vol. 31, no. 3, pp. 502-512, 2009.
14. E. K. Persson, E. Jaensson, and W. W. Agace, "The diverse ontogeny and function of murine small intestinal dendritic cell/macrophage subsets, " Immunobiology, vol. 215, no. 9-10, pp. 692-697, 2010.
15. C. Varol, E. Zigmond, and S. Jung, "Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria, " Nature Reviews Immunology, vol. 10, no. 6, pp. 415-426, 2010.
16. J. H. Niess, S. Brand, X. Gu et al. , "CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance, " Science, vol. 307, no. 5707, pp. 254-258, 2005.
17. M. Chieppa, M. Rescigno, A. Y. C. Huang, and R. N. Germain, "Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement, "The Journal of ExperimentalMedicine, vol. 203, no. 13, pp. 2841-2852, 2006.
18. A. Vallon-Eberhard, L. Landsman, N. Yogev, B. Verrier, and S. Jung, "Transepithelial pathogen uptake into the small intestinal lamina propria, " Journal of Immunology, vol. 176, no. 4, pp. 2465-2469, 2006.
19. T. L. Denning, Y.-C. Wang, S. R. Patel, I. R. Williams, and B. Pulendran, "Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses, " Nature Immunology, vol. 8, no. 10, pp. 1086-1094, 2007.
20. T. L. Denning, B. A. Norris, O. Medina-Contreras et al. , "Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization, " Journal of Immunology, vol. 187, no. 2, pp. 733-747, 2011.
21. H. Azukizawa, A. Dhler, N. Kanazawa et al. , "Steady state migratory RelB+ langerin+ dermal dendritic cells mediate peripheral induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells, " European Journal of Immunology, vol. 41, no. 5, pp. 1420-1434, 2011.
22. M. Guilliams, K. Crozat, S. Henri et al. , "Skin-draining lymph nodes contain dermis-derived CD103-dendritic cells that constitutively produce retinoic acid and induce Foxp3+ regulatory T cells, " Blood, vol. 115, no. 10, pp. 1958-1968, 2010.
23. S. Bedoui, P. G. Whitney, J. Waithman et al. , "Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells, " Nature Immunology, vol. 10, no. 5, pp. 488-495, 2009.
24. S. Henri, L. F. Poulin, S. Tamoutounour et al. , "CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells, " The Journal of Experimental Medicine, vol. 207, no. 1, pp. 189-206, 2010.
25. L. Ohl, M. Mohaupt, N. Czeloth et al. , "CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions, " Immunity, vol. 21, no. 2, pp. 279-288, 2004.
26. J. A. Hall, J. R. Grainger, S. P. Spencer, and Y. Belkaid, "The role of retinoic acid in tolerance and immunity, " Immunity, vol. 35, no. 1, pp. 13-22, 2011.
27. C. H. Kim, "Roles of retinoic acid in induction of immunity and immune tolerance, " Endocrine, Metabolic and Immune Disorders-Drug Targets, vol. 8, no. 4, pp. 289-294, 2008.
28. J. W. Fluhr, M.-P. Vienne, C. Lauze, P. Dupuy, W. Gehring, and M. Gloor, "Tolerance profile of retinol, retinaldehyde and retinoic acid under maximized and long-term clinical conditions, " Dermatology, vol. 199, supplement 1, pp. 57-60, 1999.
29. R. Kurzrock, E. Estey, and M. Talpaz, "All-trans retinoic acid: tolerance and biologic effects in myelodysplastic syndrome, " Journal of Clinical Oncology, vol. 11, no. 8, pp. 1489-1495, 1993.
30. J. R. Mora, M. Iwata, B. Eksteen et al. , "Generation of guthoming IgA-secreting B cells by intestinal dendritic cells, " Science, vol. 314, no. 5802, pp. 1157-1160, 2006.
31. M. Iwata, A. Hirakiyama, Y. Eshima, H. Kagechika, C. Kato, and S.-Y. Song, "Retinoic acid imprints gut-homing specificity on T cells, " Immunity, vol. 21, no. 4, pp. 527-538, 2004.
32. S. G. Kang, H. W. Lim, O. M. Andrisani, H. E. Broxmeyer, and C. H. Kim, "Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells, " The Journal of Immunology, vol. 179, no. 6, pp. 3724-3733, 2007.
33. M. Svensson, B. Johansson-Lindbom, F. Zapata et al. , "Retinoic acid receptor signaling levels and antigen dose regulate gut homing receptor expression on CD8+ T cells, " Mucosal Immunology, vol. 1, no. 1, pp. 38-48, 2008.
34. H. Takeuchi, A. Yokota, Y. Ohoka et al. , "Efficient induction of CCR9 on T cells requires coactivation of retinoic acid receptors and retinoid X receptors (RXRs): exaggerated T cell homing to the intestine by RXR activation with organotins, " The Journal of Immunology, vol. 185, no. 9, pp. 5289-5299, 2010.
35. A. Harusato, K. L. Flannigan, D. Geem, and T. L. Denning, "Phenotypic and functional profiling of mouse intestinal antigen presenting cells, " Journal of Immunological Methods, vol. 421, pp. 20-26, 2015.
36. S. D. Lyman, L. James, J. Zappone, P. R. Sleath, M. P. Beckmann, and T. Bird, "Characterization of the protein encoded by the flt3 (flk2) receptor-like tyrosine kinase gene, " Oncogene, vol. 8, no. 4, pp. 815-822, 1993.
37. O. Rosnet, S. Marchetto, O. deLapeyriere, and D. Birnbaum, "Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family, " Oncogene, vol. 6, no. 9, pp. 1641-1650, 1991.
38. O. Rosnet, C. Schiff, M.-J. Pbusque et al. , "Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells, " Blood, vol. 82, no. 4, pp. 1110-1119, 1993.
39. K. Brasel, S. Escobar, R. Anderberg, P. de Vries, H.-J. Gruss, and S. D. Lyman, "Expression of the flt3 receptor and its ligand on hematopoietic cells, " Leukemia, vol. 9, no. 7, pp. 1212-1218, 1995.
40. S. D. Lyman, L. James, L. Johnson et al. , "Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells, " Blood, vol. 83, no. 10, pp. 2795-2801, 1994.
41. D. K. Fogg, C. Sibon, C. Miled et al. , "A clonogenic bone marrow progenitor specific for macrophages and dendritic cells, " Science, vol. 311, no. 5757, pp. 83-87, 2006.
42. A. DAmico and L. Wu, "The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3, " The Journal of Experimental Medicine, vol. 198, no. 2, pp. 293-303, 2003.
43. H. Karsunky, M. Merad, A. Cozzio, I. L. Weissman, and M. G. Manz, "Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo, " The Journal of Experimental Medicine, vol. 198, no. 2, pp. 305-313, 2003.
44. S. H. Naik, P. Sathe, H.-Y. Park et al. , "Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo, " Nature Immunology, vol. 8, no. 11, pp. 1217-1226, 2007.
45. N. Onai, A. Obata-Onai, M. A. Schmid, T. Ohteki, D. Jarrossay, and M. G. Manz, "Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow, " Nature Immunology, vol. 8, no. 11, pp. 1207-1216, 2007.
46. J. Aliberti, O. Schulz, D. J. Pennington et al. , "Essential role for ICSBP in the in vivo development of murine CD8α + dendritic cells, " Blood, vol. 101, no. 1, pp. 305-310, 2003.
47. H. Tsujimura, T. Tamura, C. Gongora et al. , "ICSBP/IRF-8 retrovirus transduction rescues dendritic cell development in vitro, " Blood, vol. 101, no. 3, pp. 961-969, 2003.
48. G. Schiavoni, F. Mattei, P. Sestili et al. , "ICSBP is essential for the developmentofmouse type I interferon-producing cells and for the generation and activation of CD8α + dendritic cells, " The Journal of ExperimentalMedicine, vol. 196, no. 11, pp. 1415-1425, 2002.
49. K. L. Anderson, H. Perkin, C. D. Surh, S. Venturini, R. A. Maki, and B. E. Torbett, "Transcription factor PU. 1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells, " The Journal of Immunology, vol. 164, no. 4, pp. 1855-1861, 2000.
50. A. Guerriero, P. B. Langmuir, L. M. Spain, and E. W. Scott, "PU. 1 is required formyeloid-derived but not lymphoid-derived dendritic cells, " Blood, vol. 95, no. 3, pp. 879-885, 2000.
51. N. Onai, A. Obata-Onai, R. Tussiwand, A. Lanzavecchia, and M. G. Manz, "Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development, " The Journal of Experimental Medicine, vol. 203, no. 1, pp. 227-238, 2006.
52. K. M. Murphy, "Transcriptional control of dendritic cell development, " Advances in Immunology, vol. 120, pp. 239-267, 2013.
53. F. Ginhoux, K. Liu, J. Helft et al. , "The origin and development of nonlymphoid tissue CD103+ DCs, "The Journal of Experimental Medicine, vol. 206, no. 13, pp. 3115-3130, 2009.
54. N. S. Wilson, D. El-Sukkari, G. T. Belz et al. , "Most lymphoid organ dendritic cell types are phenotypically and functionally immature, " Blood, vol. 102, no. 6, pp. 2187-2194, 2003.
55. S. Uematsu, K. Fujimoto, M. H. Jang et al. , "Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5, " Nature Immunology, vol. 9, no. 7, pp. 769-776, 2008.
56. A. Iwasaki and B. L. Kelsall, "Unique functions of CD11b+, CD8α +, and double-negative Peyers patch dendritic cells, " Journal of Immunology, vol. 166, no. 8, pp. 4884-4890, 2001.
57. N. Kamada, S.-U. Seo, G. Y. Chen, and G. Nnez, "Role of the gut microbiota in immunity and inflammatory disease, " Nature Reviews Immunology, vol. 13, no. 5, pp. 321-335, 2013.
58. N. Kamada, G. Y. Chen, N. Inohara, and G. Nnez, "Control of pathogens and pathobionts by the gut microbiota, " Nature Immunology, vol. 14, no. 7, pp. 685-690, 2013.
59. M. Lotz, D. Gtle, S. Walther, S. Mnard, C. Bogdan, and M. W. Hornef, "Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells, "The Journal of ExperimentalMedicine, vol. 203, no. 4, pp. 973-984, 2006.
60. L. E. Smythies, M. Sellers, R. H. Clements et al. , "Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity, " The Journal of Clinical Investigation, vol. 115, no. 1, pp. 66-75, 2005.
61. W. S. Garrett, G. M. Lord, S. Punit et al. , "Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system, " Cell, vol. 131, no. 1, pp. 33-45, 2007.
62. T. Hudcovic, R. Stepnkov, J. Cebra, and H. Tlaskalov-Hogenov, "The role of microflora in the development of intestinal inflammation: acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice, " Folia Microbiologica, vol. 46, no. 6, pp. 565-572, 2001.
63. D. Kirkland, A. Benson, J. Mirpuri et al. , "B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage, " Immunity, vol. 36, no. 2, pp. 228-238, 2012.
64. S. Kitajima, M. Morimoto, E. Sagara, C. Shimizu, and Y. Ikeda, "Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice, " Experimental Animals, vol. 50, no. 5, pp. 387-395, 2001.
65. M. Vijay-Kumar, C. J. Sanders, R. T. Taylor et al. , "Deletion of TLR5 results in spontaneous colitis in mice, " The Journal of Clinical Investigation, vol. 117, no. 12, pp. 3909-3921, 2007.
66. S. M. Bloom, V. N. Bijanki, G. M. Nava et al. , "Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease, " Cell Host and Microbe, vol. 9, no. 5, pp. 390-403, 2011.
67. W. S. Garrett, C. A. Gallini, T. Yatsunenko et al. , "Enterobacteriaceae Act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis, " Cell Host and Microbe, vol. 8, no. 3, pp. 292-300, 2010.
68. O. Takeuchi and S. Akira, "Pattern recognition receptors and inflammation, " Cell, vol. 140, no. 6, pp. 805-820, 2010.
69. K. Schroder, R. Zhou, and J. Tschopp, "The NLRP3 inflammasome: a sensor formetabolic danger?" Science, vol. 327, no. 5963, pp. 296-300, 2010.
70. L. Franchi, N. Kamada, Y. Nakamura et al. , "NLRC4-driven production of IL-1β discriminates between pathogenic and commensal bacteria and promotes host intestinal defense, " Nature Immunology, vol. 13, no. 5, pp. 449-456, 2012.
71. C. Bauer, P. Duewell, H.-A. Lehr, S. Endres, and M. Schnurr, "Protective and aggravating effects of Nlrp3 inflammasome activation in IBDmodels: influence of genetic and environmental factors, " Digestive Diseases, vol. 30, no. 1, pp. 82-90, 2012.
72. C. Bauer, P. Duewell, C. Mayer et al. , "Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome, " Gut, vol. 59, no. 9, pp. 1192-1199, 2010.
73. I. C. Allen, E. M. Tekippe, R.-M. T. Woodford et al. , "TheNLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer, " Journal of Experimental Medicine, vol. 207, no. 5, pp. 1045-1056, 2010.
74. M. H. Zaki, K. L. Boyd, P. Vogel, M. B. Kastan, M. Lamkanfi, and T.-D. Kanneganti, "The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis, " Immunity, vol. 32, no. 3, pp. 379-391, 2010.
75. M. Coccia, O. J. Harrison, C. Schiering et al. , "IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells, " Journal of ExperimentalMedicine, vol. 209, no. 9, pp. 1595-1609, 2012.
76. T. Saitoh, N. Fujita, M. H. Jang et al. , "Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production, " Nature, vol. 456, no. 7219, pp. 264-268, 2008.
77. K. Schaale, K. M. Peters, A. M. Murthy et al. , "Strain-and host species-specific inflammasome activation, IL-1β release, and cell death in macrophages infected with uropathogenic Escherichia coli, "Mucosal Immunology, vol. 9, no. 1, pp. 124-136, 2015.
78. H. Yen, N. Sugimoto, and T. Tobe, "Enteropathogenic Escherichia coli uses NleA to inhibit NLRP3 inflammasome activation, " PLoS Pathogens, vol. 11, no. 9, Article ID e1005121, 2015.
79. N. Baba, S. Samson, R. L. Bourdet-Sicard, M. Rubio, and M. Sarfati, "Commensal bacteria trigger a full dendritic cell maturation program that promotes the expansion of non-Tr1 suppressor T cells, " Journal of Leukocyte Biology, vol. 84, no. 2, pp. 468-476, 2008.
80. S. K. Mazmanian, H. L. Cui, A. O. Tzianabos, and D. L. Kasper, "An immunomodulatorymolecule of symbiotic bacteria directs maturation of the host immune system, " Cell, vol. 122, no. 1, pp. 107-118, 2005.
81. I. I. Ivanov, K. Atarashi, N. Manel et al. , "Induction of intestinal Th17 cells by segmented filamentous bacteria, " Cell, vol. 139, no. 3, pp. 485-498, 2009.
82. K. Atarashi, J. Nishimura, T. Shima et al. , "ATP drives lamina propria TH17 cell differentiation, " Nature, vol. 455, no. 7214, pp. 808-812, 2008.
83. S. Laffont, K. R. R. Siddiqui, and F. Powrie, "Intestinal inflammation abrogates the tolerogenic properties of MLN CD103+ dendritic cells, " European Journal of Immunology, vol. 40, no. 7, pp. 1877-1883, 2010.
84. C. L. Scott, A. M. Aumeunier, and A. M. Mowat, "Intestinal CD103+ dendritic cells: master regulators of tolerance?" Trends in Immunology, vol. 32, no. 9, pp. 412-419, 2011.
85. M. Semmrich, M. Plantinga, M. Svensson-Frej et al. , "Directed antigen targeting in vivo identifies a role for CD103+ dendritic cells in both tolerogenic and immunogenic T-cell responses, " Mucosal Immunology, vol. 5, no. 2, pp. 150-160, 2012.
86. F. Powrie, M. W. Leach, S. Mauze, S. Menon, L. B. Caddle, and R. L. Coffman, "Inhibition ofTh1responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells, " Immunity, vol. 1, no. 7, pp. 553-562, 1994.
87. J.-B. Sun, S. Raghavan, A. Sjling, S. Lundin, and J. Holmgren, "Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25-CD4+ regulatory T cells, " Journal of Immunology, vol. 177, no. 11, pp. 7634-7644, 2006.
88. A. Yokota, H. Takeuchi, N. Maeda et al. , "GM-CSF and IL-4 synergistically trigger dendritic cells to acquire retinoic acidproducing capacity, " International Immunology, vol. 21, no. 4, pp. 361-377, 2009.
89. S. Bereswill, M. Munoz, A. Fischer et al. , "Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation, " PLoS ONE, vol. 5, no. 12, Article ID e15099, 2010.
90. F. Fallarino, U. Grohmann, S. You et al. , "The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells, " The Journal of Immunology, vol. 176, no. 11, pp. 6752-6761, 2006.
91. R. Elgueta, F. E. Sepulveda, F. Vilches et al. , "Imprinting ofCCR9 on CD4 T cells requires IL-4 signaling on mesenteric lymph node dendritic cells, " Journal of Immunology, vol. 180, no. 10, pp. 6501-6507, 2008.
92. S. Chmill, S. Kadow, M. Winter, H. Weighardt, and C. Esser, "2, 3, 7, 8-tetrachlorodibenzo-p-dioxin impairs stable establishment of oral tolerance in mice, " Toxicological Sciences, vol. 118, no. 1, pp. 98-107, 2010.
93. T. Takamura, D. Harama, S. Fukumoto et al. , "Lactobacillus bulgaricus OLL1181 activates the aryl hydrocarbon receptor pathway and inhibits colitis, " Immunology and Cell Biology, vol. 89, no. 7, pp. 817-822, 2011.
94. C. McBerry, R. M. S. Gonzalez, N. Shryock, A. Dias, and J. Aliberti, "SOCS2-induced proteasome-dependent TRAF6 degradation: a common anti-inflammatory pathway for control of innate immune responses, " PLoS ONE, vol. 7, no. 6, Article ID e38384, 2012.
95. T. Varga and L. Nagy, "Nuclear receptors, transcription factors linking lipidmetabolism and immunity: the case of peroxisome proliferator-activated receptor gamma, " European Journal of Clinical Investigation, vol. 38, no. 10, pp. 695-707, 2008.
96. J. H. Cummings, E. W. Pomare, H. W. J. Branch, C. P. E. Naylor, and G. T. MacFarlane, "Short chain fatty acids in human large intestine, portal, hepatic and venous blood, " Gut, vol. 28, no. 10, pp. 1221-1227, 1987.
97. C. Nastasi, M. Candela, C. M. Bonefeld et al. , "The effect of short-chain fatty acids on human monocyte-derived dendritic cells, " Scientific Reports, vol. 5, article 16148, 2015.
98. N. Singh, A. Gurav, S. Sivaprakasam et al. , "Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis, " Immunity, vol. 40, no. 1, pp. 128-139, 2014.
99. Y. Cong, L. Wang, A. Konrad, T. Schoeb, and C. O. Elson, "Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine-protective regulatory T cells, " European Journal of Immunology, vol. 39, no. 11, pp. 3134-3146, 2009.
100. C. T. Taylor and S. J. Keely, "The autonomic nervous system and inflammatory bowel disease, " Autonomic Neuroscience: Basic and Clinical, vol. 133, no. 1, pp. 104-114, 2007.
101. Y. Weng, J. Sun, Q. Wu, and J. Pan, "Regulatory effects of vasoactive intestinal peptide on the migration of mature dendritic cells, " Journal of Neuroimmunology, vol. 182, no. 1-2, pp. 48-54, 2007.
102. M. G. Toscano, M. Delgado, W. Kong, F. Martin, M. Skarica, and D. Ganea, "Dendritic cells transduced with lentiviral vectors expressing vip differentiate into vip-secreting tolerogenic-like DCs, " MolecularTherapy, vol. 18, no. 5, pp. 1035-1045, 2010.
103. M. Delgado, E. Gonzalez-Rey, and D. Ganea, "Theneuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells, " The Journal of Immunology, vol. 175, no. 11, pp. 7311-7324, 2005.
104. M. Delgado, A. Chorny, E. Gonzalez-Rey, and D. Ganea, "Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo, " Journal of Leukocyte Biology, vol. 78, no. 6, pp. 1327-1338, 2005.
105. E. Gonzalez-Rey and M. Delgado, "Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide, " Gastroenterology, vol. 131, no. 6, pp. 1799-1811, 2006.